Diagnostics

Floreo Bolsters Autism Services with Autism Eyes Acquisition, Cleveland Clinic Investment

Behavioral health-focused virtual reality company Floreo has acquired Autism Eyes, an autism diagnostic tool developed by Cleveland Clinic Innovations. This news coincides with an announcement that Cleveland Clinic has made a strategic investment in Floreo. Founded in 2016, Floreo uses a virtual reality platform to help neurodiverse individuals develop new skills. The platform allows therapists […]

Floreo Bolsters Autism Services with Autism Eyes Acquisition, Cleveland Clinic Investment Read More »

Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer

Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc., has announced the acquisition of Cirrus Bio for an undisclosed amount. Cirrus Bio develops and brings to market multiomic solutions for the diagnosis and management of diseases where early detection plays a critical role in clinical outcomes. As part of

Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer Read More »

Assure Holdings Closes Sale of Certain Assets to MPOWERHealth

Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announces that it closed the sale of certain assets of its IONM business to MPOWERHealth on March 26, 2024. The sale includes proceeds of up to $4.5 million, of which $2.32 million was paid in cash

Assure Holdings Closes Sale of Certain Assets to MPOWERHealth Read More »

Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announces that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. Through this transaction, Labcorp will acquire BioReference

Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business Read More »

US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing. The transaction expands the capabilities, expertise, and geographic footprint of the combined organization, providing more testing options to customers and accelerating the development

US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories Read More »

Scroll to Top